If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStratmin Global Resources Regulatory News (STGR)

  • There is currently no data for STGR

Trading Update

1 Nov 2010 14:25

RNS Number : 3875V
Directex Realisations Plc
01 November 2010
 

 

 

Directex Realisations plc

 

("DXR" or the "Company")

 

 

Trading Update

 

Barclays Warrants

 

On 24 October 2008 the Company executed a share warrant instrument (the "Warrant Instrument") in favour of Barclays Converted Instruments (No.2) Limited ("Barclays"), constituting and regulating warrants to subscribe for up to 3,000,000 ordinary shares in the Company at a subscription price of £0.004 per share (the "Warrants").

 

On 28 October 2010, the Group and Barclays agreed that the Warrant Instrument be terminated and the Warrants cancelled on payment by the Company to Barclays of £24,000. This payment has now been made and on receipt by the Company of the warrant certificate, the Warrants will be cancelled.

 

 

 

For further information:

 

Directex Realisations plc

Jonathan Lander, Chairman

Tel: + 44 (0) 7634 9700

 

Libertas Capital Corporate Finance Limited

Sandy Jamieson

Tel: + 44 (0) 7569 9650

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFSLVLLIII
Date   Source Headline
23rd Sep 20057:01 amRNSInterim Results
20th Sep 20051:38 pmRNSHolding(s) in Company
20th Sep 20059:16 amRNSContract Gain
13th Sep 200510:11 amRNSInterims Briefings
9th Sep 200511:00 amRNSHolding(s) in Company
2nd Sep 20054:07 pmRNSNotice of Results
25th Aug 20057:00 amRNSHolding(s) in Company
16th Jun 200511:22 amRNSHolding(s) in Company
9th Mar 20057:01 amRNSFinal Results
9th Mar 20057:01 amRNSHolding(s) in Company
28th Jan 200511:28 amRNSDisposal
13th Jan 200512:29 pmRNSDirector Shareholding
7th Jan 200512:29 pmRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.